Get the Daily Brief
Latest Biotech News
10x Genomics Acquires Scale Biosciences to Expand Single-Cell Platform
10x Genomics announced an acquisition of Scale Biosciences for $30 million upfront plus milestone payments, aiming to enhance its Chromium single-cell biology platform with Scale’s split-pool...
Adaptive Biotechnologies Reports Strong Q2 on MRD Testing Growth
Adaptive Biotechnologies posted a 36% year-over-year revenue increase to $58.9 million for the second quarter driven primarily by its minimal residual disease (MRD) testing business. Revenues from...
Jazz Pharmaceuticals Gains FDA Approval for Rare Pediatric Brain Cancer Drug
Jazz Pharmaceuticals secured accelerated FDA approval for dordaviprone (Modeyso), the first systemic treatment for recurrent H3 K27M-mutant diffuse midline glioma, a rare and aggressive brain...
Merck Acquires Verona Pharma in $10 Billion Deal Without Competition
Merck closed its $10 billion acquisition of Verona Pharma, a transaction uncontested by other bidders despite Verona’s recent FDA approval of OhtuvayreTM, a novel nebulized treatment for chronic...
Deep Learning and AI Fuel Medical Imaging and Diagnostic Innovations
Recent studies highlight the rapid integration of deep learning and artificial intelligence across medical imaging and diagnostics. Advances include enhanced cranial ultrasound methods for brain...
HHS Ends mRNA Vaccine Development: Impact on Future Biotech
The U.S. Department of Health and Human Services (HHS) has announced the termination of 22 contracts, canceling nearly $500 million in funding for mRNA vaccine development at the Biomedical...
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Drugs
Strand Therapeutics, an MIT spinout pioneering programmable messenger RNA-based therapies aimed at solid tumors, has secured $153 million in Series B funding. The capital will accelerate clinical...
Eli Lilly’s Oral GLP-1 Obesity Pill Shows Modest Weight Loss in Phase 3
Eli Lilly has reported results from a pivotal Phase 3 trial of orforglipron, an oral GLP-1 receptor agonist for obesity, demonstrating an average weight loss of 11.2% at 72 weeks for the highest...
10x Genomics Acquires Scale Biosciences, Reports Revenue Dip
10x Genomics has agreed to acquire Scale Biosciences for $30 million upfront plus milestone payments, aiming to enhance its single-cell genomics platform with Scale’s innovative combinatorial...
PacBio Posts 7% Revenue Growth as Sequencing Demand Rises
Pacific Biosciences reported 7% year-over-year revenue growth in Q2 2025, totaling $39.8 million, driven primarily by consumables. Although instrument sales dipped slightly due to fewer...
Neonatal and Pediatric Imaging Innovations Enhance Diagnostic Precision
Recent research in pediatric radiology and neonatal medicine highlights advances in imaging and clinical approaches to enhance outcomes. Studies include: development of automated deep learning...
Novel Therapeutics and Molecular Targets in Cancer Research
Cutting-edge discoveries continue to deepen understanding of cancer biology and therapeutic opportunities. Highlights include: Genomic identification of follicular lymphoma subtypes with distinct...
Energy Storage and Battery Technology Breakthroughs
Researchers present significant advancements in materials and predictive models vital to energy storage technologies. Innovations include cathode nanoparticles enhancing zinc-ion battery...
Immunology and Microbiome Insights in Health and Disease
Emerging studies shed light on pivotal immunological mechanisms and microbiome interactions affecting disease progression and therapeutic potential. Investigations reveal the gut microbiome’s...
FDA Approves Jazz’s First Drug for Rare Pediatric Brain Cancer
Jazz Pharmaceuticals secured accelerated FDA approval for dordaviprone (Modeyso), the first systemic treatment targeting recurrent H3 K27M-mutant diffuse midline glioma, a rare and aggressive...
HHS Shifts Strategy, Cuts $500M from mRNA Vaccine Programs
In a controversial move, the U.S. Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., announced the termination of 22 BARDA-funded mRNA vaccine development contracts...
Strand Therapeutics Raises $153M to Advance mRNA Cancer Programs
Strand Therapeutics, a biotech developing programmable mRNA therapies aimed at orchestrating protein expression in tumor cells, closed a $153 million Series B financing round. Led by Kinnevik and...
10x Genomics Acquires Scale Biosciences to Boost Single-Cell Scale
10x Genomics expanded its single-cell technology portfolio by acquiring Scale Biosciences for an upfront $30 million payment plus performance-based milestones. Scale's split-pool combinatorial...
Novo Nordisk Faces Headwinds — Pipeline Pruning and Legal Challenges
Novo Nordisk announced discontinuation of multiple pipeline programs amid leadership transition and lower obesity drug sales growth forecasts. The company is confronting fierce competition from...
Bio-Techne’s Fiscal Growth Amid Macroeconomic and NIH Funding Concerns
Bio-Techne posted a 4 percent revenue increase in Q4 fiscal 2025 to $317 million, driven by strong demand in protein sciences and cell therapy workflow solutions despite a 1 percent decline in...